Tsedey Tsegaye had her sights on a career in health communication—until a civil war upended her life. A scholarship...
Takeaways from day three of the AACR Annual Meeting 2025 included the inspiring Opening Ceremony, a panel on cancer...
In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
The final day of AACR IO highlighted the emerging frontier of glyco-immunology.
Immune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night...
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
This quarterly series on creative approaches to cancer research includes urine-powered nanomotors, unique molds to grow organoids, and more.
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...